Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review-Reference-Cited by-同舟云学术

Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review

Published:2021-01-04 Issue:1 Volume:40 Page:341-354
ISSN:0167-7659
Container-title:Cancer and Metastasis Reviews
language:en
Short-container-title:Cancer Metastasis Rev

Author:

Borius Pierre-Yves^ORCID,Régis Jean,Carpentier Alexandre,Kalamarides Michel,Valery Charles Ambroise,Latorzeff Igor

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10555-020-09949-9.pdf

Reference84 articles.

1. Yamamoto, M., Higuchi, Y., Sato, Y., Aiyama, H., Kasuya, H., & Barfod, B. E. (2019). Stereotactic radiosurgery for patients with 10 or more brain metastases. In A. Niranjan, L. D. Lunsford, & H. Kano (Eds.), Progress in neurological surgery (Vol. 34, pp. 110–124). S. Karger AG. https://doi.org/10.1159/000493056.

2. Tallet, A. V., Dhermain, F., Le Rhun, E., Noël, G., & Kirova, Y. M. (2017). Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy. Annals of Oncology, 28(12), 2962–2976. https://doi.org/10.1093/annonc/mdx408.

3. Anker, C. J., Grossmann, K. F., Atkins, M. B., Suneja, G., Tarhini, A. A., & Kirkwood, J. M. (2016). Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: consensus guidelines from the Eastern Cooperative Oncology Group (ECOG). International Journal of Radiation Oncology, Biology, Physics, 95(2), 632–646. https://doi.org/10.1016/j.ijrobp.2016.01.038.

4. Verduin, M., Zindler, J. D., Martinussen, H. M. A., Jansen, R. L. H., Croes, S., Hendriks, L. E. L., Eekers, D. B. P., & Hoeben, A. (2017). Use of systemic therapy concurrent with cranial radiotherapy for cerebral metastases of solid tumors. Oncologist, 22(2), 222–235. https://doi.org/10.1634/theoncologist.2016-0117.

5. Levy, A., Faivre-Finn, C., Hasan, B., De Maio, E., Berghoff, A. S., Girard, N., et al. (2018). Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey. European Journal of Cancer, 93, 37–46. https://doi.org/10.1016/j.ejca.2018.01.067.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Brain Metastases: A Review of Novel Therapies;Seminars in Neurology;2023-11-27

2. Let’s make size not matter: tumor control and toxicity outcomes of hypofractionated Gamma Knife radiosurgery for large brain metastases;Journal of Neuro-Oncology;2023-07

3. Retrospective non-inferiority study of stereotactic radiosurgery for more than ten brain metastases;Journal of Neuro-Oncology;2023-06

4. Novel Mechanisms and Future Opportunities for the Management of Radiation Necrosis in Patients Treated for Brain Metastases in the Era of Immunotherapy;Cancers;2023-04-24

5. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis;Open Life Sciences;2023-01-01